Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. (Q36508312)
Jump to navigation
Jump to search
scientific article published on 28 November 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes. |
scientific article published on 28 November 2012 |
Statements
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes (English)
Y Zhou
D R Laybutt
J Luzuriaga
28 November 2012
28 November 2012
1 reference
2 references
1 reference
1 reference
1 reference
1 reference